Brookdale Senior Living Inc. 7.
Brookdale Senior Living Inc. 7. BKDT Peers
See (BKDT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BKDT | $77.60 | -2.62% | 16.6B | N/A | N/A | N/A |
| HCA | $378.71 | +0.32% | 91.1B | 16.61 | $22.80 | +0.73% |
| FMS | $27.16 | +1.29% | 15.9B | 22.44 | $1.21 | +2.51% |
| THC | $169.25 | +0.74% | 15.7B | 10.85 | $15.60 | N/A |
| SOLV | $73.25 | -0.43% | 12.7B | 33.76 | $2.17 | N/A |
| EHC | $120.23 | +0.88% | 12.1B | 24.74 | $4.86 | +0.55% |
| UHS | $173.60 | +1.11% | 11.2B | 9.75 | $17.81 | +0.46% |
| DVA | $136.35 | -0.43% | 10.3B | 13.53 | $10.08 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $152.17 | -0.89% | 8.7B | 28.71 | $5.30 | +0.16% |
Stock Comparison
BKDT vs HCA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, HCA has a market cap of 91.1B. Regarding current trading prices, BKDT is priced at $77.60, while HCA trades at $378.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 16.61. In terms of profitability, BKDT's ROE is -0.96%, compared to HCA's ROE of -2.36%. Regarding short-term risk, BKDT is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs FMS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, FMS has a market cap of 15.9B. Regarding current trading prices, BKDT is priced at $77.60, while FMS trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 22.44. In terms of profitability, BKDT's ROE is -0.96%, compared to FMS's ROE of +0.04%. Regarding short-term risk, BKDT is less volatile compared to FMS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs THC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, THC has a market cap of 15.7B. Regarding current trading prices, BKDT is priced at $77.60, while THC trades at $169.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas THC's P/E ratio is 10.85. In terms of profitability, BKDT's ROE is -0.96%, compared to THC's ROE of +0.37%. Regarding short-term risk, BKDT is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SOLV Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SOLV has a market cap of 12.7B. Regarding current trading prices, BKDT is priced at $77.60, while SOLV trades at $73.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SOLV's P/E ratio is 33.76. In terms of profitability, BKDT's ROE is -0.96%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, BKDT is less volatile compared to SOLV. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs EHC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, BKDT is priced at $77.60, while EHC trades at $120.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 24.74. In terms of profitability, BKDT's ROE is -0.96%, compared to EHC's ROE of +0.25%. Regarding short-term risk, BKDT is less volatile compared to EHC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs UHS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, UHS has a market cap of 11.2B. Regarding current trading prices, BKDT is priced at $77.60, while UHS trades at $173.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 9.75. In terms of profitability, BKDT's ROE is -0.96%, compared to UHS's ROE of +0.18%. Regarding short-term risk, BKDT is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs DVA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, DVA has a market cap of 10.3B. Regarding current trading prices, BKDT is priced at $77.60, while DVA trades at $136.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 13.53. In terms of profitability, BKDT's ROE is -0.96%, compared to DVA's ROE of +3.94%. Regarding short-term risk, BKDT is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs OSH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, BKDT is priced at $77.60, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, BKDT's ROE is -0.96%, compared to OSH's ROE of +4.64%. Regarding short-term risk, BKDT is less volatile compared to OSH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ENSG Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ENSG has a market cap of 8.7B. Regarding current trading prices, BKDT is priced at $77.60, while ENSG trades at $152.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 28.71. In terms of profitability, BKDT's ROE is -0.96%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, BKDT is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CHE Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CHE has a market cap of 8.1B. Regarding current trading prices, BKDT is priced at $77.60, while CHE trades at $550.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 26.87. In terms of profitability, BKDT's ROE is -0.96%, compared to CHE's ROE of +0.26%. Regarding short-term risk, BKDT is less volatile compared to CHE. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs LHCG Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, BKDT is priced at $77.60, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, BKDT's ROE is -0.96%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, BKDT is less volatile compared to LHCG. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs OPCH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, OPCH has a market cap of 5.1B. Regarding current trading prices, BKDT is priced at $77.60, while OPCH trades at $31.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 24.84. In terms of profitability, BKDT's ROE is -0.96%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, BKDT is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AMED Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, BKDT is priced at $77.60, while AMED trades at $97.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 36.11. In terms of profitability, BKDT's ROE is -0.96%, compared to AMED's ROE of +0.10%. Regarding short-term risk, BKDT is less volatile compared to AMED. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SGRY Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SGRY has a market cap of 2.6B. Regarding current trading prices, BKDT is priced at $77.60, while SGRY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is -13.20. In terms of profitability, BKDT's ROE is -0.96%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, BKDT is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ADUS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, BKDT is priced at $77.60, while ADUS trades at $113.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 25.57. In terms of profitability, BKDT's ROE is -0.96%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, BKDT is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs LFST Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, LFST has a market cap of 1.9B. Regarding current trading prices, BKDT is priced at $77.60, while LFST trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas LFST's P/E ratio is -55.11. In terms of profitability, BKDT's ROE is -0.96%, compared to LFST's ROE of -0.02%. Regarding short-term risk, BKDT is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ACHC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ACHC has a market cap of 1.9B. Regarding current trading prices, BKDT is priced at $77.60, while ACHC trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is 10.22. In terms of profitability, BKDT's ROE is -0.96%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, BKDT is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SEM Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SEM has a market cap of 1.9B. Regarding current trading prices, BKDT is priced at $77.60, while SEM trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 24.03. In terms of profitability, BKDT's ROE is -0.96%, compared to SEM's ROE of +0.10%. Regarding short-term risk, BKDT is less volatile compared to SEM. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ARDT Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ARDT has a market cap of 1.9B. Regarding current trading prices, BKDT is priced at $77.60, while ARDT trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 7.71. In terms of profitability, BKDT's ROE is -0.96%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, BKDT is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AMEH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, BKDT is priced at $77.60, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, BKDT's ROE is -0.96%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, BKDT is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs NHC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, NHC has a market cap of 1.7B. Regarding current trading prices, BKDT is priced at $77.60, while NHC trades at $106.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 15.48. In terms of profitability, BKDT's ROE is -0.96%, compared to NHC's ROE of +0.11%. Regarding short-term risk, BKDT is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs BKD Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, BKD has a market cap of 1.6B. Regarding current trading prices, BKDT is priced at $77.60, while BKD trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -6.65. In terms of profitability, BKDT's ROE is -0.96%, compared to BKD's ROE of -0.96%. Regarding short-term risk, BKDT is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ASTH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ASTH has a market cap of 1.3B. Regarding current trading prices, BKDT is priced at $77.60, while ASTH trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 34.34. In terms of profitability, BKDT's ROE is -0.96%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, BKDT is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs MD Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, MD has a market cap of 1.1B. Regarding current trading prices, BKDT is priced at $77.60, while MD trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas MD's P/E ratio is -13.36. In terms of profitability, BKDT's ROE is -0.96%, compared to MD's ROE of -0.11%. Regarding short-term risk, BKDT is less volatile compared to MD. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs USPH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, BKDT is priced at $77.60, while USPH trades at $75.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 34.67. In terms of profitability, BKDT's ROE is -0.96%, compared to USPH's ROE of +0.06%. Regarding short-term risk, BKDT is less volatile compared to USPH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs HCSG Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, HCSG has a market cap of 1B. Regarding current trading prices, BKDT is priced at $77.60, while HCSG trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 25.54. In terms of profitability, BKDT's ROE is -0.96%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, BKDT is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs PNTG Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, PNTG has a market cap of 972.7M. Regarding current trading prices, BKDT is priced at $77.60, while PNTG trades at $28.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 37.13. In terms of profitability, BKDT's ROE is -0.96%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, BKDT is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AVAH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AVAH has a market cap of 950.1M. Regarding current trading prices, BKDT is priced at $77.60, while AVAH trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 162.33. In terms of profitability, BKDT's ROE is -0.96%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, BKDT is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AGL Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AGL has a market cap of 894.1M. Regarding current trading prices, BKDT is priced at $77.60, while AGL trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -3.48. In terms of profitability, BKDT's ROE is -0.96%, compared to AGL's ROE of -0.44%. Regarding short-term risk, BKDT is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AMN Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AMN has a market cap of 811.3M. Regarding current trading prices, BKDT is priced at $77.60, while AMN trades at $21.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AMN's P/E ratio is -4.89. In terms of profitability, BKDT's ROE is -0.96%, compared to AMN's ROE of -0.21%. Regarding short-term risk, BKDT is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs INNV Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, INNV has a market cap of 533.3M. Regarding current trading prices, BKDT is priced at $77.60, while INNV trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas INNV's P/E ratio is -16.46. In terms of profitability, BKDT's ROE is -0.96%, compared to INNV's ROE of -0.12%. Regarding short-term risk, BKDT is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CYH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CYH has a market cap of 471.4M. Regarding current trading prices, BKDT is priced at $77.60, while CYH trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CYH's P/E ratio is -0.91. In terms of profitability, BKDT's ROE is -0.96%, compared to CYH's ROE of +0.30%. Regarding short-term risk, BKDT is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs EHAB Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, EHAB has a market cap of 469.4M. Regarding current trading prices, BKDT is priced at $77.60, while EHAB trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -3.35. In terms of profitability, BKDT's ROE is -0.96%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, BKDT is less volatile compared to EHAB. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TALK Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TALK has a market cap of 461.8M. Regarding current trading prices, BKDT is priced at $77.60, while TALK trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 138.00. In terms of profitability, BKDT's ROE is -0.96%, compared to TALK's ROE of -0.04%. Regarding short-term risk, BKDT is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AUNA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AUNA has a market cap of 461.5M. Regarding current trading prices, BKDT is priced at $77.60, while AUNA trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 9.90. In terms of profitability, BKDT's ROE is -0.96%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, BKDT is less volatile compared to AUNA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SNDA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SNDA has a market cap of 458M. Regarding current trading prices, BKDT is priced at $77.60, while SNDA trades at $24.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -6.69. In terms of profitability, BKDT's ROE is -0.96%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, BKDT is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CCRN Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CCRN has a market cap of 436M. Regarding current trading prices, BKDT is priced at $77.60, while CCRN trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CCRN's P/E ratio is -24.63. In terms of profitability, BKDT's ROE is -0.96%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, BKDT is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TALKW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TALKW has a market cap of 426.8M. Regarding current trading prices, BKDT is priced at $77.60, while TALKW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, BKDT is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AONC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AONC has a market cap of 406.3M. Regarding current trading prices, BKDT is priced at $77.60, while AONC trades at $13.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AONC's P/E ratio is -15.61. In terms of profitability, BKDT's ROE is -0.96%, compared to AONC's ROE of +0.25%. Regarding short-term risk, BKDT is less volatile compared to AONC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AIRS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AIRS has a market cap of 302.7M. Regarding current trading prices, BKDT is priced at $77.60, while AIRS trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -16.72. In terms of profitability, BKDT's ROE is -0.96%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, BKDT is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TOIIW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TOIIW has a market cap of 224M. Regarding current trading prices, BKDT is priced at $77.60, while TOIIW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to TOIIW's ROE of -5.10%. Regarding short-term risk, BKDT is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CSU Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, BKDT is priced at $77.60, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, BKDT's ROE is -0.96%, compared to CSU's ROE of +2.23%. Regarding short-term risk, BKDT is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CMPS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CMPS has a market cap of 218.2M. Regarding current trading prices, BKDT is priced at $77.60, while CMPS trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CMPS's P/E ratio is -1.18. In terms of profitability, BKDT's ROE is -0.96%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, BKDT is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TOI Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TOI has a market cap of 210.5M. Regarding current trading prices, BKDT is priced at $77.60, while TOI trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -3.27. In terms of profitability, BKDT's ROE is -0.96%, compared to TOI's ROE of -5.10%. Regarding short-term risk, BKDT is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs JYNT Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, JYNT has a market cap of 169.7M. Regarding current trading prices, BKDT is priced at $77.60, while JYNT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is -110.90. In terms of profitability, BKDT's ROE is -0.96%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, BKDT is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs DCGO Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, DCGO has a market cap of 167.5M. Regarding current trading prices, BKDT is priced at $77.60, while DCGO trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -169.00. In terms of profitability, BKDT's ROE is -0.96%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, BKDT is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs BTMD Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, BTMD has a market cap of 153.9M. Regarding current trading prices, BKDT is priced at $77.60, while BTMD trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 6.93. In terms of profitability, BKDT's ROE is -0.96%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, BKDT is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs FVE Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, BKDT is priced at $77.60, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, BKDT's ROE is -0.96%, compared to FVE's ROE of -0.15%. Regarding short-term risk, BKDT is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs KDLYW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, BKDT is priced at $77.60, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas KDLYW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, BKDT is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs MODV Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, MODV has a market cap of 48.7M. Regarding current trading prices, BKDT is priced at $77.60, while MODV trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.21. In terms of profitability, BKDT's ROE is -0.96%, compared to MODV's ROE of +6.87%. Regarding short-term risk, BKDT is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ALR Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, BKDT is priced at $77.60, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, BKDT's ROE is -0.96%, compared to ALR's ROE of -0.15%. Regarding short-term risk, BKDT is less volatile compared to ALR. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CCEL Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CCEL has a market cap of 41.1M. Regarding current trading prices, BKDT is priced at $77.60, while CCEL trades at $5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is 508.00. In terms of profitability, BKDT's ROE is -0.96%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, BKDT is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs IMAC Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, BKDT is priced at $77.60, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, BKDT's ROE is -0.96%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, BKDT is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs PIII Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, PIII has a market cap of 20.2M. Regarding current trading prices, BKDT is priced at $77.60, while PIII trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.12. In terms of profitability, BKDT's ROE is -0.96%, compared to PIII's ROE of -1.29%. Regarding short-term risk, BKDT is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AIH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, BKDT is priced at $77.60, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, BKDT's ROE is -0.96%, compared to AIH's ROE of +1.16%. Regarding short-term risk, BKDT is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs AMS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, AMS has a market cap of 15.1M. Regarding current trading prices, BKDT is priced at $77.60, while AMS trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas AMS's P/E ratio is 11.16. In terms of profitability, BKDT's ROE is -0.96%, compared to AMS's ROE of +0.06%. Regarding short-term risk, BKDT is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CANO Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, BKDT is priced at $77.60, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, BKDT's ROE is -0.96%, compared to CANO's ROE of -1.49%. Regarding short-term risk, BKDT is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs FTRP Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, BKDT is priced at $77.60, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, BKDT's ROE is -0.96%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, BKDT is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs MNDR Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, MNDR has a market cap of 5.5M. Regarding current trading prices, BKDT is priced at $77.60, while MNDR trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.18. In terms of profitability, BKDT's ROE is -0.96%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, BKDT is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs GBNH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, BKDT is priced at $77.60, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, BKDT's ROE is -0.96%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, BKDT is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs RHE Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, BKDT is priced at $77.60, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, BKDT's ROE is -0.96%, compared to RHE's ROE of +1.52%. Regarding short-term risk, BKDT is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs ATIP Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, ATIP has a market cap of 3.8M. Regarding current trading prices, BKDT is priced at $77.60, while ATIP trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas ATIP's P/E ratio is -0.04. In terms of profitability, BKDT's ROE is -0.96%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, BKDT and ATIP have similar daily volatility (0.00).
BKDT vs IMACW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, BKDT is priced at $77.60, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, BKDT is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs NIVFW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, NIVFW has a market cap of 917.4K. Regarding current trading prices, BKDT is priced at $77.60, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas NIVFW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, BKDT is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SYRA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SYRA has a market cap of 895.4K. Regarding current trading prices, BKDT is priced at $77.60, while SYRA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SYRA's P/E ratio is -0.23. In terms of profitability, BKDT's ROE is -0.96%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, BKDT is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs CCM Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, CCM has a market cap of 839.4K. Regarding current trading prices, BKDT is priced at $77.60, while CCM trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.59. In terms of profitability, BKDT's ROE is -0.96%, compared to CCM's ROE of +0.13%. Regarding short-term risk, BKDT is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs RHE-PA Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, BKDT is priced at $77.60, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, BKDT's ROE is -0.96%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, BKDT is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs BACK Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, BACK has a market cap of 189.2K. Regarding current trading prices, BKDT is priced at $77.60, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas BACK's P/E ratio is -0.01. In terms of profitability, BKDT's ROE is -0.96%, compared to BACK's ROE of +2.46%. Regarding short-term risk, BKDT and BACK have similar daily volatility (0.00).
BKDT vs IONM Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, IONM has a market cap of 149.8K. Regarding current trading prices, BKDT is priced at $77.60, while IONM trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas IONM's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to IONM's ROE of +0.75%. Regarding short-term risk, BKDT is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs NVOS Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, NVOS has a market cap of 43.4K. Regarding current trading prices, BKDT is priced at $77.60, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas NVOS's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, BKDT and NVOS have similar daily volatility (0.00).
BKDT vs PIIIW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, PIIIW has a market cap of 27.8K. Regarding current trading prices, BKDT is priced at $77.60, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, BKDT's ROE is -0.96%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, BKDT and PIIIW have similar daily volatility (0.00).
BKDT vs NFH Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, NFH has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, BKDT's ROE is -0.96%, compared to NFH's ROE of -0.06%. Regarding short-term risk, BKDT is less volatile compared to NFH. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TLMD Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, BKDT's ROE is -0.96%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, BKDT is less volatile compared to TLMD. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TVTY Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, BKDT's ROE is -0.96%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, BKDT is less volatile compared to TVTY. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SLHGP Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, BKDT's ROE is -0.96%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, BKDT and SLHGP have similar daily volatility (0.00).
BKDT vs HNGR Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, BKDT's ROE is -0.96%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, BKDT is less volatile compared to HNGR. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs SLHG Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, BKDT's ROE is -0.96%, compared to SLHG's ROE of N/A. Regarding short-term risk, BKDT is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs TLMDW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, BKDT is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs DVCR Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, BKDT's ROE is -0.96%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, BKDT is less volatile compared to DVCR. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.
BKDT vs DCGOW Comparison
BKDT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BKDT stands at 16.6B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, BKDT is priced at $77.60, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BKDT currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, BKDT's ROE is -0.96%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, BKDT is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for BKDT.